Humanized anti-CD3 antibodies, conjugates and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12252534
APP PUB NO 20230192844A1
SERIAL NO

16074600

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides for humanized anti-CD3 antibodies and conjugates thereof. These conjugates may be useful in the treatment of conditions such as prostate cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • THE SCRIPPS RESEARCH INSTITUTE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kim, Chanhyuk Daejeon, KR 15 178
Kim, Minsoo San Diego, US 333 2222
Ma, Jennifer Los Angeles, US 8 55
Presta, Leonard San Francisco, US 74 3705
Schultz, Peter G La Jolla, US 236 4625
Young, Travis La Jolla, US 40 429

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Sep 18, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 18, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 18, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00